FR2383943A1 - Triazinones, leur procede de preparation et leur application en therapeutique - Google Patents

Triazinones, leur procede de preparation et leur application en therapeutique

Info

Publication number
FR2383943A1
FR2383943A1 FR7807170A FR7807170A FR2383943A1 FR 2383943 A1 FR2383943 A1 FR 2383943A1 FR 7807170 A FR7807170 A FR 7807170A FR 7807170 A FR7807170 A FR 7807170A FR 2383943 A1 FR2383943 A1 FR 2383943A1
Authority
FR
France
Prior art keywords
triazinones
therapeutics
application
preparation process
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7807170A
Other languages
English (en)
Other versions
FR2383943B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB11757/77A external-priority patent/GB1601132A/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2383943A1 publication Critical patent/FR2383943A1/fr
Application granted granted Critical
Publication of FR2383943B1 publication Critical patent/FR2383943B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention a pour objet des dérivés de triazinone de formule :
FR7807170A 1977-03-19 1978-03-13 Triazinones, leur procede de preparation et leur application en therapeutique Granted FR2383943A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11757/77A GB1601132A (en) 1977-03-19 1977-03-19 Pharmacologically active triazinones
GB1182877 1977-03-21

Publications (2)

Publication Number Publication Date
FR2383943A1 true FR2383943A1 (fr) 1978-10-13
FR2383943B1 FR2383943B1 (fr) 1980-08-29

Family

ID=26248492

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7807170A Granted FR2383943A1 (fr) 1977-03-19 1978-03-13 Triazinones, leur procede de preparation et leur application en therapeutique

Country Status (15)

Country Link
US (2) US4185103A (fr)
JP (1) JPS53116392A (fr)
AT (1) AT358593B (fr)
AU (1) AU514811B2 (fr)
CA (1) CA1124717A (fr)
CH (1) CH638804A5 (fr)
DE (1) DE2811477A1 (fr)
FR (1) FR2383943A1 (fr)
IE (1) IE46966B1 (fr)
IL (1) IL54111A (fr)
IN (1) IN147613B (fr)
LU (1) LU79266A1 (fr)
NL (1) NL7802959A (fr)
NZ (1) NZ186511A (fr)
ZM (1) ZM3278A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374836A (en) * 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
JPS56115777A (en) * 1980-02-19 1981-09-11 Sumitomo Chem Co Ltd 3-thiooxo-5-oxo-hexahydro-1,2,4-triazine, its preparation, herbicide and germicide comprising it as active ingredient
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
CA1275097A (fr) 1984-10-02 1990-10-09 Fujio Nohara Derives de pyridyloxy
CN103483249A (zh) * 2012-10-09 2014-01-01 南京理工大学 一种2，3，5，6-四氨基吡啶盐酸盐的合成方法
CN104788473B (zh) * 2015-03-25 2017-03-15 石家庄学院 一种具有抗菌能力的化合物及其制备方法与用途
EP4196793A1 (fr) 2020-08-11 2023-06-21 Université de Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH288889A (de) * 1950-08-01 1953-02-15 Ag J R Geigy Verfahren zur Herstellung eines Derivates des 1,2,4-Triazins.
GB713540A (en) * 1950-08-01 1954-08-11 Geigy Ag J R Improvements in and relating to 1:2:4-triazine derivatives
DE1670912C3 (de) * 1967-08-18 1981-06-11 Bayer Ag, 5090 Leverkusen Herbizide Mittel auf Basis von 1,2,4-Triazin-5-onen
BE786840A (fr) * 1971-07-29 1973-01-29 Bayer Ag Procede de preparation de 1,2,4-triazine -5-ones
GB1419994A (en) 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (fr) 1975-10-02 1979-08-25 Smith Kline French Lab
MW5076A1 (en) 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors

Also Published As

Publication number Publication date
FR2383943B1 (fr) 1980-08-29
US4185103A (en) 1980-01-22
IL54111A0 (en) 1978-04-30
AU3379278A (en) 1979-09-06
JPS53116392A (en) 1978-10-11
NL7802959A (nl) 1978-09-21
CA1124717A (fr) 1982-06-01
IN147613B (fr) 1980-05-03
NZ186511A (en) 1980-11-14
CH638804A5 (de) 1983-10-14
ZM3278A1 (en) 1978-12-21
ATA190478A (de) 1980-02-15
AT358593B (de) 1980-09-25
US4220767A (en) 1980-09-02
AU514811B2 (en) 1981-02-26
LU79266A1 (fr) 1978-06-29
IL54111A (en) 1981-07-31
IE780542L (en) 1978-09-19
DE2811477A1 (de) 1978-09-21
IE46966B1 (en) 1983-11-16

Similar Documents

Publication Publication Date Title
FR2435248A1 (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
FR2383187A1 (fr) Derives du cepheme, leur procede de preparation et leur application en therapeutique
FR2383157A1 (fr) Derives de chalcone, leur procede de preparation et leur application en therapeutique
FR2392016A1 (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
FR2385722A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique
FR2381028A1 (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
FR2405246A1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et leurs applications en therapeutique
FR2364219A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application en therapeutique
FR2400500A1 (fr) Derives d'acides cycloalcoylidenemethylphenylacetiques, leur procede de preparation et leur application en therapeutique
FR2446283A1 (fr) Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques
FR2387988A1 (fr) Esters de cefuroxime, leur preparation et leur application therapeutique
FR2453151A1 (fr) Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique
FR2378016A1 (fr) 1-alkylthiophenyl-2,3,4,5-tetrahydro-1h-3-benzazepine substituees et leur application en therapeutique
FR2391203A1 (fr) 2-phenyl-1,2,4-triazine-3,5-(2h,4h)-diones substituees, leur procede de preparation, et compositions coccidiostatiques en contenant
FR2383943A1 (fr) Triazinones, leur procede de preparation et leur application en therapeutique
FR2431494A1 (fr) Nouveaux derives du benzofuranne, leur procede de preparation et leur application en therapeutique
FR2392959A1 (fr) Amino-acides et procede d'obtention
FR2385720A1 (fr) Thieno(2,3-c) et (3,2-c) pyridines, leur procede de preparation et leur application en therapeutique
FR2383944A1 (fr) Derives de bis-benzimidazolyle substitues, leur procede de preparation et leur application en therapeutique
FR2355831A1 (fr) Derives de benzazocine, leur procede de preparation et leur application therapeutique
FR2453163A1 (fr) Derives de benzothiazole, leur procede de preparation et leurs applications en therapeutique
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique
FR2390445A1 (fr) Nouveaux derives du chromene, leur procede de preparation et leurs applications en therapeutique
FR2399406A1 (fr) Derives de perhydronaphtalenepentol et leur utilisation therapeutique
FR2405936A1 (fr) Derives du pyrrole, leur procede de preparation et leurs applications, notamment en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse